Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Kazlauskas, Egidijus ^a   Petrikaite, Vilma ^a,b   Michailoviene, Vilma ^a   Revuckiene, Jurgita ^a   Matuliene, Jurgita ^a   Grinius, Leonas ^a   Matulis, Daumantas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

5 ARYL 4 (5 2,4 DIHYDROXYPHENYL) 1,2,3 THIADIAZOLE DERIVATIVE; BUFFER; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; ICPD 26; ICPD 34; ICPD 47; ICPD 62; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEPROTONATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENERGY TRANSFER; ENTHALPY; ENTROPY; GIBBS FREE ENERGY; HEAT; HELA CELL; HUMAN; HUMAN CELL; ISOTHERMAL TITRATION CALORIMETRY; NONHUMAN; OSTEOSARCOMA; PH; PROTON TRANSPORT; THERMAL ANALYSIS; THERMAL SHIFT ASSAY; THERMODYNAMICS; CALORIMETRY; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; PROTEIN BINDING;

CALORIMETRY; HSP90 HEAT-SHOCK PROTEINS; HUMANS; PROTEIN BINDING; THERMODYNAMICS; THIADIAZOLES;

EID: 84861398030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036899     Document Type: Article

References (52)

1. Taldone T, Sun W, Chiosis G, (2009) Discovery and development of heat shock protein 90 inhibitors. Bioorg Med Chem 17: 2225-35.
2. Wandinger SK, Richter K, Buchner J, (2008) The hsp90 chaperone machinery. J Biol Chem 283: 18473-7.
3. Banz VM, Medov M, Keogh A, Furer C, Zimmer Y, et al. (2009) Hsp90 transcriptionally and post-translationally regulates the expression of ndrg1 and maintains the stability of its modifying kinase gsk3beta. Biochim Biophys Acta 1793: 1597-1603.
4. Mayer MP, Prodromou C, Frydman J, (2009) The hsp90 mosaic: a picture emerges. Nat Struct Mol Biol 16: 2-6.
5. Neckers L, Mollapour M, Tsutsumi S, (2009) The complex dance of the molecular chaperone hsp90. Trends Biochem Sci 34: 223-226.
6. Neckers L, Tsutsumi S, Mollapour M, (2009) Visualizing the twists and turns of a molecular chaperone. Nat Struct Mol Biol 16: 235-6.
7. Taipale M, Jarosz DF, Lindquist S, (2010) Hsp90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-528.
8. Vaughan CK, Neckers L, Piper PW, (2010) Understanding of the hsp90 molecular chaperone reaches new heights. Nat Struct Mol Biol 17: 1400-1404.
9. Walerych D, Olszewski MB, Gutkowska M, Helwak A, Zylicz M, et al. (2009) Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions. Oncogene 28: 4284-94.
10. Biamonte MA, de Water RV, Arndt JW, Scannevin RH, Perret D, et al. (2010) Heat shock protein 90: inhibitors in clinical trials. J Med Chem 53: 3-17.
11. Fukuyo Y, Hunt CR, Horikoshi N, (2010) Geldanamycin and its anti-cancer activities. Cancer Lett 290: 24-35.
12. Sgobba M, Rastelli G, (2009) Structure-based and in silico design of hsp90 inhibitors. ChemMedChem 4: 1399-409.
13. Sharp SY, Boxall K, Rowlands M, Prodromou C, Roe SM, et al. (2007) In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitors. Cancer Res 67: 2206-16.
14. van Montfort RL, Workman P, (2009) Structure-based design of molecular cancer therapeutics. Trends Biotechnol 27: 315-28.
15. Zuehlke A, Johnson JL, (2010) Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers 93: 211-217.
16. Chiosis G, Lucas B, Shtil A, Huezo H, Rosen N, (2002) Development of a purine-scaffold novel class of hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of her2 tyrosine kinase. Bioorg Med Chem 10: 3555-64.
17. Taldone T, Zatorska D, Patel PD, Zong H, Rodina A, et al. (2011) Design, synthesis, and evaluation of small molecule hsp90 probes. Bioorg Med Chem 19: 2603-2614.
18. Cheung KM, Matthews TP, James K, Rowlands MG, Boxall KJ, et al. (2005) The identification, synthesis, protein crystal structure and in vitro biochemical evaluation of a new 3,4-diarylpyrazole class of hsp90 inhibitors. Bioorg Med Chem Lett 15: 3338-43.
19. Dymock BW, Barril X, Brough PA, Cansfield JE, Massey A, et al. (2005) Novel, potent small-molecule inhibitors of the molecular chaperone hsp90 discovered through structure-based design. J Med Chem 48: 4212-5.
20. Brough PA, Barril X, Borgognoni J, Chene P, Davies NG, et al. (2009) Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the hsp90 molecular chaperone. J Med Chem 52: 4794-809.
21. Huang KH, Veal JM, Fadden RP, Rice JW, Eaves J, et al. (2009) Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents. J Med Chem 52: 4288-305.
22. Kung PP, Huang B, Zhang G, Zhou JZ, Wang J, et al. (2010) Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone. J Med Chem 53: 499-503.
23. Petrikaite V, Matulis D, (2011) Application of Thermodynamics to Biological and Materials Science, InTech, chapter Thermodynamics of Natural and Synthetic Inhibitor Binding to Human Hsp90 pp. 77-92.
24. Petrikaite V, Matulis D, (2011) Binding of natural and synthetic inhibitors to human heat shock protein 90 and their clinical application. Medicina (Kaunas) 47: 413-420.
25. Cikotiene I, Kazlauskas E, Matuliene J, Michailoviene V, Torresan J, et al. (2009) 5-aryl-4-(5-substituted-2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone. Bioorg Med Chem Lett 19: 1089-1092.
26. Freire E, (2004) Isothermal titration calorimetry: controlling binding forces in lead optimization. Drug Discov Today: Technologies 1: 295-299.
27. Velazquez Campoy A, Freire E, (2005) Itc in the post-genomic era..? priceless. Biophys Chem 115: 115-24.
28. Freire E, (2008) Do enthalpy and entropy distinguish first in class from best in class? Drug Discov Today 13: 869-74.
29. Ladbury JE, Klebe G, Freire E, (2010) Adding calorimetric data to decision making in lead discovery: a hot tip. Nat Rev Drug Discov 9: 23-27.
30. Nilapwar S, Williams E, Fu C, Prodromou C, Pearl LH, et al. (2009) Structural-thermodynamic relationships of interactions in the n-terminal atp-binding domain of hsp90. J Mol Biol 392: 923-36.
31. Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, et al. (2004) Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem 332: 153-9.
32. Niesen FH, Berglund H, Vedadi M, (2007) The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc 2: 2212-21.
33. Pantoliano MW, Petrella EC, Kwasnoski JD, Lobanov VS, Myslik J, et al. (2001) High-density miniaturized thermal shift assays as a general strategy for drug discovery. J Biomol Screen 6: 429-440.
34. Velazquez-Campoy A, Ohtaka H, Nezami A, Muzammil S, Freire E, (2004) Isothermal titration calorimetry. Curr Protoc Cell Biol Chapter 17: Unit 17 8.
35. Baker BM, Murphy KP, (1996) Evaluation of linked protonation effects in protein binding reactions using isothermal titration calorimetry. Biophysical Journal 71 (4): 2049-55.
36. Doyle ML, Louie G, Dal Monte PR, Sokoloski TD, (1995) Tight binding affinities determined from thermodynamic linkage to protons by titration calorimetry. Methods Enzymol 259: 183-94.
37. Cimmperman P, Baranauskiene L, Jachimoviciute S, Jachno J, Torresan J, et al. (2008) A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys J 95: 3222-3231.
38. Todd M, Salemme FR, (2003) Direct binding assays for pharma screening. Genetic Eng News 23: 28-29.
39. Matulis D, Kranz JK, Salemme FR, Todd MJ, (2005) Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using thermofluor. Biochemistry 44: 5258-5266.
40. Baker BM, Murphy KP, (1997) Dissecting the energetics of a protein-protein interaction: the binding of ovomucoid third domain to elastase. Journal of Molecular Biology 268 (2): 557-69.
41. Jelesarov I, Bosshard HR, (1999) Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J Mol Recognit 12: 3-18.
42. Wiseman T, Williston S, Brandts JF, Lin LN, (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Analytical biochemistry 179: 131-7.
43. Cimmperman P, Matulis D, (2011) Protein thermal denaturation measurements via a fluorescent dye, RSC Publishing, chapter 8 pp. 247-274.
44. Anderson SR, Weber G, (1969) Fluorescence polarization of the complexes of 1-anilino-8-naphthalenesulfonate with bovine serum albumin. evidence for preferential orientation of the ligand. Biochemistry 8: 371-7.
45. Matulis D, Baumann CG, Bloomfield VA, Lovrien RE, (1999) 1-anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopolymers 49: 451-8.
46. Matulis D, Lovrien R, (1998) 1-anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophys J 74: 422-9.
47. Zubriene A, Gutkowska M, Matuliene J, Chaleckis R, Michailoviene V, et al. (2010) Thermodynamics of radicicol binding to human hsp90 alpha and beta isoforms. Biophys Chem 152: 153-163.
48. Toleikis Z, Cimmperman P, Petrauskas V, Matulis D, (2011) Determination of the volume changes induced by ligand binding to heat shock protein 90 using high-pressure denaturation. Anal Biochem 413: 171-178.
49. Zubriene A, Matuliene J, Baranauskiene L, Jachno J, Torresan J, et al. (2009) Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay- radicicol binding to hsp90 and ethoxzolamide binding to caii. Int J Mol Sci 10: 2662-2680.
50. Prabhu NV, Sharp KA, (2005) Heat capacity in proteins. Annu Rev Phys Chem 56: 521-48.
51. Barril X, Beswick MC, Collier A, Drysdale MJ, Dymock BW, et al. (2006) 4-amino derivatives of the hsp90 inhibitor cct018159. Bioorg Med Chem Lett 16: 2543-2548.
52. Bradshaw JM, Waksman G, (1998) Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the src sh2 domain with a high-affinity tyrosyl phosphopeptide. Biochemistry 37: 15400-7.